Dr. Reddy's Laboratories
RDY
#1799
Rank
C$17.00 B
Marketcap
C$20.42
Share price
2.79%
Change (1 day)
0.36%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): C$1.21 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are C$3.95 Billion. a decrease over its 2024 earnings that were of C$1.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$1.24 B-2.73%
2024 C$1.27 B7.01%
2023 C$1.19 B32.93%
2022 C$0.89 B26.77%
2021 C$0.70 B31.44%
2020 C$0.53 B54.54%
2019 C$0.34 B-12.26%
2018 C$0.39 B23.6%
2017 C$0.32 B4.47%
2016 C$0.30 B-55.7%
2015 C$0.69 B1.83%
2014 C$0.68 B-3.78%
2013 C$0.70 B54.07%
2012 C$0.45 B-16.23%
2011 C$0.54 B56.66%
2010 C$0.35 B-235.36%
2009 -C$0.26 Billion-198.53%
2008 C$0.26 B30.77%
2007 C$0.20 B-14.61%
2006 C$0.23 B703.63%
2005 C$29.24 M649.45%
2004 C$3.9 M-95.68%
2003 C$90.24 M-14.86%
2002 C$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.41 B 1,707.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$15.03 B 1,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.87 B 776.90%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
C$14.21 B 1,046.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$3.22 B 160.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel